May 9th, 2013
Journal X: Not so Subtle Marketing Messages
Eric Lindley, MD
My 3-year-old daughter helps me see the influence of pharma on research.
September 19th, 2012
An Ad That Doesn’t Tell the Entire Story — Part 2: Niaspan
Harlan M. Krumholz, MD, SM
A print ad for Niaspan focuses only on how it raises HDL-cholesterol levels, with no mention of the lack of benefit in improving outcomes.
September 11th, 2012
Advertising That Falls Short — Part 1: Omega-3 Fatty-Acid Supplements
Harlan M. Krumholz, MD, SM
What is the role of a clinician in putting misleading ads in context for patients?
NEJM Journal Watch — Recent Cardiology Articles- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?